A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients

BACKGROUND: Biochemical recurrence (BCR) is considered a decisive risk factor for clinical recurrence and the metastasis of prostate cancer (PCa). Therefore, we developed and validated a signature which could be used to accurately predict BCR risk and aid in the selection of PCa treatments. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Androl Urol
Main Authors: Wu, Xiangkun, Lv, Daojun, Eftekhar, Md, Khan, Aisha, Cai, Chao, Zhao, Zhijian, Gu, Di, Liu, Yongda
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807327/
https://ncbi.nlm.nih.gov/pubmed/33457230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados